ShRNA-mediated silencing of ANXA1 suppresses nuclear factor (NF)-kB activity, which results in the direct inhibition of CXCR4 and matrix metalloproteinase (MMP) expression, impeding tumor cell invasion [54]. Here, ANXA1 is linked to neoplasm.